Concussions Market Research Report - Global Forecast till 2030

脳震盪市場:エンドユーザー(病院および診療所、診断センターおよび支払者)および地域別の治療(診断および治療)別情報-2030年までの世界予測

ID: MRFR/Pharma/4269-CR | July 2019 | Region: Global | 145 Pages         

1 Executive Summary

2 Market Introduction

2.1 Definition 18

2.2 Scope of the Study 18

2.3 Market Structure 18

3 Research Methodology

3.1 Research Process 19

3.2 Primary Research 20

3.3 Secondary Research 21

3.4 Market Size Estimation 22

3.5 Forecast Model 22

4 Market Dynamics

4.1 Overview 23

4.2 Drivers 23

4.2.1 Increasing Incidence of Mild Traumatic Brain Injuries 24

4.2.2 Ongoing Product Development and Approval 24

4.2.3 Growing Geriatric Population 24

4.3 Restraints 25

4.3.1 Stringent Regulatory Framework 25

4.3.2 Shortage of Trained Professionals 25

4.4 Opportunities 25

4.4.1 Growing Awareness about Concussions 25

5 Market Factor Analysis

5.1.1 R&D and Designing 26

5.1.2 Manufacturing 26

5.1.3 Distribution & Sales 27

5.1.4 Post-Sales Services 27

5.2 Porter’s Five Forces Analysis 27

5.2.1 Bargaining Power of Suppliers 28

5.2.2 Bargaining Power of Buyers 28

5.2.3 Threat of New Entrants 28

5.2.4 Threat of Substitutes 28

5.2.5 Intensity of Rivalry 28

5.3 Investment Opportunities 29

5.4 Pricing Analysis 29

6 Global Concussions Market by Diagnosis & Treatment

6.1 Overview 30

6.2 Diagnosis 31

6.3 Treatment 33

7 Global Concussions Market, by End User

7.1 Overview 35

7.2 Hospitals and Clinics 36

7.3 Diagnostic Centers 37

7.4 Payers 37

8 Global Concussions Market, by Region

8.1 Overview 38

8.2 Americas 40

8.2.1 North America 43

8.2.1.1 US 45

8.2.1.2 Canada 47

8.2.2 Latin America 49

8.3 Europe 51

8.3.1 Western Europe 53

8.3.1.1 Germany 56

8.3.1.2 France 57

8.3.1.3 UK 59

8.3.1.4 Italy 61

8.3.1.5 Spain 62

8.3.1.6 Rest of Western Europe 64

8.3.2 Eastern Europe 66

8.4 Asia-Pacific 68

8.4.1 China 71

8.4.2 Japan 73

8.4.3 India 74

8.4.4 Australia 76

8.4.5 South Korea 78

8.4.6 Rest of Asia-Pacific 80

8.5 Middle East & Africa 82

8.5.1 Middle East 85

8.5.2 Africa 87

9 Competitive Landscape

9.1 Competitive Scenario 89

9.2 Prominent Players in the Concussion Therapeutics Industry 89

9.3 Prominent Players in the Concussion Diagnostic Industry 90

9.4 Key Developments 91

10 Company Profile

10.1 Teva Pharmaceutical Industries Ltd 94

10.1.1 Company Overview 94

10.1.2 Financial Overview 94

10.1.3 Products/Services Offered 95

10.1.4 Key Developments 95

10.1.5 SWOT Analysis 95

10.1.6 Key Strategies 96

10.2 Integra LifeSciences Corporation 97

10.2.1 Company Overview 97

10.2.2 Financial Overview 97

10.2.3 Products Offering 98

10.2.4 Key Developments 98

10.2.5 SWOT Analysis 98

10.2.6 Key Strategies 98

10.3 Medtronic PLC 99

10.3.1 Company Overview 99

10.3.2 Financial Overview 99

10.3.3 Products Offering 100

10.3.4 Key Developments 100

10.3.5 SWOT Analysis 100

10.3.6 Key Strategies 100

10.4 Sun Pharmaceutical Industries Ltd 101

10.4.1 Company Overview 101

10.4.2 Financial Overview 101

10.4.3 Products/Services Offered 102

10.4.4 Key Developments 102

10.4.5 SWOT Analysis 103

10.4.6 Key Strategies 103

10.5 Lupin 104

10.5.1 Company Overview 104

10.5.2 Financial Overview 104

10.5.3 Products/Services Offered 105

10.5.4 Key Developments 105

10.5.5 SWOT Analysis 106

10.5.6 Key Strategies 106

10.6 Zydus Cadila 107

10.6.1 Company Overview 107

10.6.2 Financial Overview 107

10.6.3 Products/Services Offered 108

10.6.4 Key Developments 108

10.6.5 SWOT Analysis 108

10.6.6 Key Strategies 108

10.7 Pfizer, Inc. 109

10.7.1 Company Overview 109

10.7.2 Financial Overview 109

10.7.3 Products/Services Offered 110

10.7.4 Key Developments 110

10.7.5 SWOT Analysis 110

10.7.6 Key Strategies 110

10.8 Mylan NV 111

10.8.1 Company Overview 111

10.8.2 Financial Overview 111

10.8.3 Products/Services Offered 112

10.8.4 Key Developments 112

10.8.5 SWOT Analysis 112

10.8.6 Key Strategies 112

10.9 Novartis AG 113

10.9.1 Company Overview 113

10.9.2 Financial Overview 113

10.9.3 Products/Services Offered 114

10.9.4 Key Developments 114

10.9.5 SWOT Analysis 114

10.9.6 Key Strategies 114

10.10 Sanofi SA 115

10.10.1 Company Overview 115

10.10.2 Financial Overview 115

10.10.3 Products/Services Offered 116

10.10.4 Key Developments 116

10.10.5 SWOT Analysis 116

10.10.6 Key Strategies 116

11 Appendix

11.1 References 117

11.2 Related Reports 117

12 List of Tables

TABLE 1 GLOBAL CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 31

TABLE 2 GLOBAL CONCUSSIONS MARKET FOR DIAGNOSIS, BY REGION, 2020–2027 (USD MILLION) 32

TABLE 3 GLOBAL CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 32

TABLE 4 GLOBAL CONCUSSIONS MARKET FOR TREATMENT, BY REGION, 2020–2027 (USD MILLION) 33

TABLE 5 GLOBAL CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 34

TABLE 6 GLOBAL CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 36

TABLE 7 GLOBAL CONCUSSIONS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 8 GLOBAL CONCUSSIONS MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 9 GLOBAL CONCUSSIONS MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION) 37

TABLE 10 GLOBAL CONCUSSIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 11 AMERICAS: CONCUSSIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 12 AMERICAS: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 41

TABLE 13 AMERICAS: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 41

TABLE 14 AMERICAS: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 42

TABLE 15 AMERICAS: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 42

TABLE 16 NORTH AMERICA: CONCUSSIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 43

TABLE 17 NORTH AMERICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 44

TABLE 18 NORTH AMERICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 44

TABLE 19 NORTH AMERICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 44

TABLE 20 NORTH AMERICA: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 45

TABLE 21 US: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 45

TABLE 22 US: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 45

TABLE 23 US: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 46

TABLE 24 US: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 46

TABLE 25 CANADA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 47

TABLE 26 CANADA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 27 CANADA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 48

TABLE 28 CANADA: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 48

TABLE 29 LATIN AMERICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 49

TABLE 30 LATIN AMERICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 49

TABLE 31 LATIN AMERICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 50

TABLE 32 LATIN AMERICA: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 50

TABLE 33 EUROPE: CONCUSSIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 34 EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 52

TABLE 35 EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 36 EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 37 EUROPE: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 53

TABLE 38 WESTERN EUROPE: CONCUSSIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 54

TABLE 39 WESTERN EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 54

TABLE 40 WESTERN EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 54

TABLE 41 WESTERN EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 42 WESTERN EUROPE: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 55

TABLE 43 GERMANY: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 56

TABLE 44 GERMANY: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 45 GERMANY: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 46 GERMANY: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 57

TABLE 47 FRANCE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 57

TABLE 48 FRANCE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 49 FRANCE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 50 FRANCE: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 58

TABLE 51 UK: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 59

TABLE 52 UK: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 53 UK: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 54 UK: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 60

TABLE 55 ITALY: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 61

TABLE 56 ITALY: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 57 ITALY: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 58 ITALY: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 62

TABLE 59 SPAIN: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 62

TABLE 60 SPAIN: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 61 SPAIN: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 62 SPAIN: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 63

TABLE 63 REST OF WESTERN EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 64

TABLE 64 REST OF WESTERN EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 65 REST OF WESTERN EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 66 REST OF WESTERN EUROPE: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 65

TABLE 67 EASTERN EUROPE: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 66

TABLE 68 EASTERN EUROPE: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 69 EASTERN EUROPE: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 70 EASTERN EUROPE: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 67

TABLE 71 ASIA-PACIFIC: CONCUSSIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 69

TABLE 72 ASIA-PACIFIC: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 69

TABLE 73 ASIA-PACIFIC: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 74 ASIA-PACIFIC: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 75 ASIA-PACIFIC: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 70

TABLE 76 CHINA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 71

TABLE 77 CHINA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 78 CHINA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 79 CHINA: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 72

TABLE 80 JAPAN: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 73

TABLE 81 JAPAN: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 82 JAPAN: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 83 JAPAN: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 74

TABLE 84 INDIA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 74

TABLE 85 INDIA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 86 INDIA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 87 INDIA: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 75

TABLE 88 AUSTRALIA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 76

TABLE 89 AUSTRALIA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 90 AUSTRALIA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 91 AUSTRALIA: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 77

TABLE 92 SOUTH KOREA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 78

TABLE 93 SOUTH KOREA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 94 SOUTH KOREA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 95 SOUTH KOREA: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 79

TABLE 96 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 80

TABLE 97 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 98 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 99 REST OF ASIA-PACIFIC: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 81

TABLE 100 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 83

TABLE 101 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 83

TABLE 102 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 103 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 104 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 84

TABLE 105 MIDDLE EAST: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 85

TABLE 106 MIDDLE EAST: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 107 MIDDLE EAST: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 108 MIDDLE EAST: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 86

TABLE 109 AFRICA: CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020–2027 (USD MILLION) 87

TABLE 110 AFRICA: CONCUSSIONS MARKET FOR DIAGNOSIS, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 111 AFRICA: CONCUSSIONS MARKET FOR TREATMENT, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 112 AFRICA: CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 88

TABLE 113 MAJOR PLAYERS IN THE CONCUSSION DIAGNOSTIC MARKET 90

TABLE 114 GLOBAL CONCUSSION MARKET: KEY DEVELOPMENT 91

13 List of Figures

FIGURE 1 MARKET SYNOPSIS 15

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL CONCUSSIONS MARKET 16

FIGURE 3 GLOBAL CONCUSSIONS MARKET SHARE, BY DIAGNOSIS AND TREATMENT, 2020 (%) 16

FIGURE 4 GLOBAL CONCUSSIONS MARKET BY DIAGNOSIS AND TREATMENT, 2020–2027 (USD MILLION) 17

FIGURE 5 GLOBAL CONCUSSIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 17

FIGURE 6 GLOBAL CONCUSSIONS MARKET BY END USER, 2020–2027 (USD MILLION) 17

FIGURE 7 GLOBAL CONCUSSIONS MARKET: MARKET STRUCTURE 18

FIGURE 8 RESEARCH PROCESS OF MRFR 19

FIGURE 9 TOP-DOWN & BOTTOM-UP APPROACH 22

FIGURE 10 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CONCUSSIONS MARKET 23

FIGURE 11 VALUE CHAIN: GLOBAL CONCUSSIONS MARKET 26

FIGURE 12 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CONCUSSIONS MARKET 27

FIGURE 13 GLOBAL CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020 (%) 30

FIGURE 14 GLOBAL CONCUSSIONS MARKET, BY DIAGNOSIS & TREATMENT, 2020 AND 2027 (USD MILLION) 30

FIGURE 15 GLOBAL CONCUSSIONS MARKET, BY END USER, 2020 (%) 35

FIGURE 16 GLOBAL CONCUSSIONS MARKET, BY END USER, 2020 AND 2027 (USD MILLION) 35

FIGURE 17 GLOBAL CONCUSSIONS MARKET, BY REGION, 2020 (%) 38

FIGURE 18 GLOBAL CONCUSSIONS MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 38

FIGURE 19 AMERICAS: CONCUSSIONS MARKET, BY REGION, 2020 AND 2027 40

FIGURE 20 NORTH AMERICA: CONCUSSIONS MARKET, BY COUNTRY, 2020 AND 2027 43

FIGURE 21 EUROPE: CONCUSSIONS MARKET, BY REGION, 2020 AND 2027 51

FIGURE 22 WESTERN EUROPE: CONCUSSIONS MARKET, BY COUNTRY, 2020 AND 2027 53

FIGURE 23 ASIA-PACIFIC: CONCUSSIONS MARKET, BY COUNTRY, 2020 AND 2027 68

FIGURE 24 MIDDLE EAST & AFRICA: CONCUSSIONS MARKET, BY REGION, 2020 AND 2027 82

FIGURE 25 MAJOR PLAYERS IN CONCUSSION THERAPEUTICS MARKET 89

FIGURE 26 GLOBAL CONCUSSION MARKET, COMPETITIVE LANDSCAPE (%) 93

脳震盪市場

脳震盪市場は、予測期間中に3.33%のCAGR成長が見込まれています。脳震盪市場は、2030年までに1億3,3717万米ドルの収益に達すると予想されています。

セグメンテーション

By Treatment Diagnosis And Treatment
End User Hospitals And Clinics Diagnostic Centers And Payers

キープレーヤー

  • Teva Pharmaceutical Industries Ltd
  • Integra LifeSciences Corporation
  • Medtronic PLC
  • Sun Pharmaceutical Industries Ltd
  • Lupin
  • Zydus Cadila
  • Pfizer
  • Inc.
  • Mylan NV
  • Novartis AG
  • Sanofi SA

運転手

  • Increasing incidence of mild traumatic brain injuries
  • The rising cases of road accidents.
Speak to Analyst Request a Free Sample

脳震盪市場の概要


脳震盪の統計に基づいて脳震盪市場は予測期間中に3.33%のCAGR成長が見込まれています。脳震盪市場は、2030年までに1億3,3717万米ドルの収益に達すると予想されています。


脳震盪は、短期間、脳の正常な機能を破壊します。これは一般に、脳の軽度の外傷性損傷です。この状況は通常、頭への衝撃や打撃によって引き起こされます。体にぶつかって頭に反射力を与えると、スポーツ、転倒、自動車事故で非常に一般的な状況が発生します。


高齢者の人口の増加に伴い、脳損傷のインシデントの増加と製品の開発の増加が、市場の成長を推進しています。しかし、訓練を受けた専門家や規制の枠組みが不足しているため、市場はさまざまな課題に直面しています。BrainScope社は最近、脳震盪とともにすべての頭部外傷を評価するためにAhead 300を立ち上げました。これらの技術的進歩は、予測期間中の脳震盪市場の成長を後押しすると予想されます。


脳震盪市場の種類は、医師によって脳震盪のレベルとしてランク付けされています。グレード1(軽度)、グレード2(中程度)、グレード3(重度)。ぼんやりや混乱感、不明瞭な発言、不器用さ、頭痛、吐き気、めまい、光に対する感受性、ぼやけた視界、だるさ、騒音に対する感受性、過敏性および行動の変化、記憶喪失、集中困難、意識喪失、疲労、物忘れ、睡眠障害、うつ病、反応の遅さ、匂いや味覚の問題。


脳震盪のための顕著な薬はありません。ただし、脳内の出血は危険で致命的になる可能性があるため、医師は怪我の最初の1時間に基本的な薬を使用します。


脳震盪市場のCovid-19の影響


新型コロナウイルスのパンデミックは、世界中の多くの業界に悪影響を及ぼしています。政府は不確実な期間のロックダウンの決定を下さなければなりませんでした。脳震盪業界も例外ではありません。多くの業界は、ロックダウンのために事業を制限せざるを得ませんでした。これらは、脳震盪市場に悪影響を与えると予想される要因です。


脳震盪市場の動態


脳震盪は軽度の頭部外傷と呼ばれていますが、影響は深刻な場合があります。脳震盪の通常の原因は、家庭内暴力、転倒、スポーツ傷害、交通事故によるけが、銃創です。米国では、脳震盪の主な原因は、転倒による52%、交通事故によるけがによる20%、打撃または衝突による17%、暴行による11%です。CDCの報告によると、スポーツ関連の怪我の量は毎年160万から380万です。したがって、米国では約5人に1人のアスリートが頭部外傷を負っていることを意味します。CDC(国立傷害予防管理センター)はまた、2018年の車両関連の傷害は約3,432人だったと述べています。


ドライバー


脳内の交通事故、暴行、ヒットまたはジャブ、家庭内暴力、転倒、スポーツ傷害の増加するケースは、予測期間中の脳震盪市場の成長に勢いを与える可能性があります。さらに、科学者によって行われた研究開発の量が増加し、脳震盪、すなわち軽度の外傷性脳損傷に関する医師の理解を向上させる努力をしています。Track TBIは、外傷性脳損傷の新しい分類を開発するための研究を着実に実施しており、これは診断とpを改善すると予想されています関連する患者の予後。


機会


脳震盪評価機械の技術開発と進歩は、脳震盪市場に大きなチャンスを生み出す可能性があります。高度なテクノロジーには、脳震盪検査の迅速なポイントオブケアが2分未満で含まれていました。また、視線追跡ベースの脳震盪テストでも改善されました。


拘束


脳震盪の分野で訓練を受けた専門家が不足していることは、脳震盪の症状に対処するための抑制要因になる可能性があります そして治療。


チャレンジ


厳格な規制の枠組みがない脳震盪市場は、困難な状況になると予想されます軽度の脳震盪の治療の因数を考慮してください。


2017年および2023年までのグローバル脳震盪市場収益 (百万米ドル)Concussions Market


ソース:MRFR 分析


セグメンテーションの概要


脳震盪市場に基づいて、それは次のように分割されます。




  • 診断と治療

  • エンドユーザ

  • 地域



診断と治療によって



診断と治療に基づいて、脳震盪市場はさらに次のように分類されます。



  • 診断

  • 治療




Report Attribute/Metric Details   Market Size   USD 1337.17 Million   CAGR   3.33% (2020-2030)   Base Year   2019   Forecast Period   2020-2030   Historical Data   2018   Forecast Units   Value (USD Million)   Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends   Segments Covered   Treatment and End User   Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)   Key Vendors   Teva Pharmaceutical Industries Ltd, Integra LifeSciences Corporation, Medtronic PLC, Sun Pharmaceutical Industries Ltd, Lupin, Zydus Cadila, Pfizer, Inc., Mylan NV, Novartis AG, Sanofi SA   Key Market Opportunities   The increase in the setups of research and development centers boosts the growth   Key Market Drivers   Increasing incidence of mild traumatic brain injuries, ongoing product development, and approval growing geriatric population

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The global concussions market is predicted to touch USD 1337.17 million by 2030.

The concussions market is predicted to grow at a 3.33% CAGR between 2020-2030.

The Americas is projected to lead the concussions market during the forecast period.

Ongoing product development, increasing prevalence of mild traumatic brain injuries, and improved healthcare infrastructure are adding to the market growth.

Lack of trained professionals and strict regulatory framework may limit market growth.